Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer.

European urology - 1 Aug 2005

Puccetti Luca, Supuran Claudiu T, Fasolo Pier P, Conti Enrico, Sebastiani Giancarlo, Lacquaniti Sergio, Mandras Roberto, Milazzo Maria G, Dogliani Natalia, De Giuli Paolo, Fasolis Giuseppe

Abstract excerpt

OBJECTIVE: The prognostic influence of neuroendocrine (NE) differentiation in prostate cancer patients is not yet properly established. In a series of primary hormone-naive prostate cancers from a patient population that underwent radical prostatectomy, we wanted to determine the relationship between NE phenotype expression and Gleason sum, disease stage, and serum PSA concentration. METHODS: Chromogranin A (CgA)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromogranins

Share to Immunohistochemistry

Share to Neurosecretory Systems

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 15992991
DOI: 10.1016/j.eururo.2005.03.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Skewing towards neuroendocrine phenotype in high grade or high stage androgen-responsive primary prostate cancer.PMID 15992991Read ↗

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.Semantic proximity Read ↗

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status.Semantic proximity Read ↗

Neuroendocrine differentiation of prostate cancer.Semantic proximity Read ↗

Immunohistochemical characterization of neuroendocrine cells in prostate cancer.Semantic proximity Read ↗

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma.Semantic proximity Read ↗

Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.Semantic proximity Read ↗

Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.Semantic proximity Read ↗

Primary Mosaic Neuroendocrine-/Adenocarcinoma of The Prostate: Clinical and Histological DescriptionSemantic proximity Read ↗

[Neuroendocrine features of prostatic tumors: state of the art].Semantic proximity Read ↗

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.Semantic proximity Read ↗

Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer.Semantic proximity Read ↗

Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.